Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow VYCOR MEDICAL INC

Get SEC filing alerts via email and in your feed for VYCOR MEDICAL INC

VYCO

VYCOR MEDICAL INC

About VYCOR MEDICAL INC

Vycor Medical, Inc. develops and markets medical devices for neurosurgery, including the ViewSite Brain Access System, and provides non-invasive vision rehabilitation therapies through NovaVision. Serving hospitals and patients worldwide, it offers minimally invasive surgical tools and digital health therapies. The company leverages regulatory approvals, innovative product development, and strategic partnerships to address neurological and vision impairment markets. Its business model focuses on device sales and therapy services in healthcare.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from VYCOR MEDICAL INC

1
1
VYCOR MEDICAL INC Vycor Medical Reports Net Income of $20,108 in Q1 2026, Significant Turnaround from Previous Year

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
VYCOR MEDICAL INC Vycor Medical Reports $1.8 Million Revenue for Fiscal Year 2025, 18% Increase Driven by International Sales

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
VYCOR MEDICAL INC Vycor Medical Reports 31% Revenue Growth in Q3 2025, Shifts Towards Profitability

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
VYCOR MEDICAL INC Vycor Medical Reports 22% Revenue Growth in Q2 2025, Achieves Net Income of $23,887

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
VYCOR MEDICAL INC Vycor Medical Reports 30% Revenue Growth to $436,378 in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
VYCOR MEDICAL INC Vycor Medical Reports $1.5 Million Revenue for Fiscal Year 2024, Faces Operating Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
VYCOR MEDICAL INC Vycor Medical Reports Mixed Financial Results for Q3 2024, with Revenue Growth and Improved Cash Position

Via official filing (AI summary) | over 1 year ago | 0 comments